newsfilter
← Latest News
GlobeNewswire·

Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder's Ownership Following Administrative Change to 13D Filing

FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), today clarified that a Schedule 13D filing by Frazier Life Sciences, which is expected to be filed later today, August